EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY

Mathurin Fumery  1     Antoine Defrance  2     Xavier Roblin  3     Carmen Stefanescu  4     Bénédicte Caron  5     Xavier Hebuterne  6     Romain Altwegg  7     Catherine Leberre  8     Maria Nachury  9     Antoine Meyer  10     Philippe Ah Soune  11     Cyrielle Gilletta De Saint Joseph  12     Nicolas DUVEAU  13     Mathieu Uzzan  14     Amelie Biron  15     David Laharie  16     Stephane NANCEY  17     My-Linh Tran-Minh  18     Ludovic Caillo  19     Thierry Paupard  20     Yasmine Elgharabawy  2     Laurent Peyrin-Biroulet  21    
1 Amiens University Hospital, Amiens, France
2 GETAID, Paris, France
3 University of St. Etienne Dept. de Gastroenterologie, Saint Etienne, France
4 Hopital Beaujon, Clichy, France
5 CHU Nancy, Nancy, France
6 Hospital Archet 2, Nice, Nice, France
7 Hopital Saint Eloi Hepatologie Gastro Enterologie, Montpellier, France
8 CHU Nantes, Nantes, France
9 CHRU Lille, Courbevoie Cedex, France
10 Hôpital Bicêtre, Bicetre, France
11 CH Toulon, Toulon, France
12 Hopital Rangueil, Toulouse, France
13 CH Roubaix, Roubaix Cedex 1, France
14 Hôpital Mondor, Paris, France
15 CHU Reims, Reims, France
16 CHU de Bordeaux, Pessac cedex, France
17 CHU Lyon, Pierre Benite, France
18 Hopital Saint-Louis, Paris, France
19 CHU de Nimes, Nîmes, France
20 CH Dunkerque, Dunkerque, France
21 Nancy University Hospital, Vandoeuvre-les-Nancy, France

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing